Skip to main content
Top
Published in: Breast Cancer Research 4/2005

Open Access 01-08-2005 | Research article

Effect of reproductive factors on stage, grade and hormone receptor status in early-onset breast cancer

Authors: Joan A Largent, Argyrios Ziogas, Hoda Anton-Culver

Published in: Breast Cancer Research | Issue 4/2005

Login to get access

Abstract

Introduction

Women younger than 35 years who are diagnosed with breast cancer tend to have more advanced stage tumors and poorer prognoses than do older women. Pregnancy is associated with elevated exposure to estrogen, which may influence the progression of breast cancer in young women. The objective of the present study was to examine the relationship between reproductive events and tumor stage, grade, estrogen receptor and progesterone receptor status, and survival in women diagnosed with early-onset breast cancer.

Methods

In a population-based, case–case study of 254 women diagnosed with invasive breast cancer at age under 35 years, odds ratios (ORs) and 95% confidence intervals (CIs) were estimated using unconditional logistic regression with tumor characteristics as dependent variables and adjusting for age and education. Survival analyses also examined the relationship between reproductive events and overall survival.

Results

Compared with nulliparous women, women with three or more childbirths were more likely to be diagnosed with nonlocalized tumors (OR = 3.1, 95% CI = 1.3–7.7), and early age (<20 years) at first full-term pregnancy was also associated with a diagnosis of breast cancer that was nonlocalized (OR = 3.0, 95% CI = 1.2–7.4) and of higher grade (OR = 3.2, 95% CI 1.0–9.9). The hazard ratio for death among women with two or more full-term pregnancies, as compared with those with one full-term pregnancy or none, was 2.1 (95% CI = 1.0–4.5), adjusting for stage. Among parous women, those who lactated were at decreased risk for both estrogen receptor and progesterone receptor negative tumors (OR = 0.2, 95% CI = 0.1–0.5, and OR = 0.4, 95% CI = 0.2–0.8, respectively).

Conclusion

The results of the present study suggest that pregnancy and lactation may influence tumor presentation and survival in women with early-onset breast cancer.
Appendix
Available only for authorised users
Literature
1.
2.
go back to reference Perkins CI, Cohen R, Morris CR, Allen M, Kwong SL, Schlag R, Wright WE: Cancer in California: 1988–1995. 1998, Sacramento, CA: California Department of Health Services, Cancer Surveillance Section Perkins CI, Cohen R, Morris CR, Allen M, Kwong SL, Schlag R, Wright WE: Cancer in California: 1988–1995. 1998, Sacramento, CA: California Department of Health Services, Cancer Surveillance Section
3.
go back to reference Winchester DP, Osteen RT, Menck HR: The National Cancer Data Base report on breast carcinoma characteristics and outcome in relation to age. Cancer. 1996, 78: 1838-1843. 10.1002/(SICI)1097-0142(19961015)78:8<1838::AID-CNCR27>3.0.CO;2-Y.CrossRefPubMed Winchester DP, Osteen RT, Menck HR: The National Cancer Data Base report on breast carcinoma characteristics and outcome in relation to age. Cancer. 1996, 78: 1838-1843. 10.1002/(SICI)1097-0142(19961015)78:8<1838::AID-CNCR27>3.0.CO;2-Y.CrossRefPubMed
4.
go back to reference Chung M, Chang HR, Bland KI, Wanebo HJ: Younger women with breast carcinoma have a poorer prognosis than older women. Cancer. 1996, 77: 97-103. 10.1002/(SICI)1097-0142(19960101)77:1<97::AID-CNCR16>3.0.CO;2-3.CrossRefPubMed Chung M, Chang HR, Bland KI, Wanebo HJ: Younger women with breast carcinoma have a poorer prognosis than older women. Cancer. 1996, 77: 97-103. 10.1002/(SICI)1097-0142(19960101)77:1<97::AID-CNCR16>3.0.CO;2-3.CrossRefPubMed
5.
go back to reference Gajdos C, Tartter PI, Bleiweiss IJ, Bodian C, Brower ST: Stage 0 to stage III breast cancer in young women. J Am Coll Surg. 2000, 190: 523-529. 10.1016/S1072-7515(00)00257-X.CrossRefPubMed Gajdos C, Tartter PI, Bleiweiss IJ, Bodian C, Brower ST: Stage 0 to stage III breast cancer in young women. J Am Coll Surg. 2000, 190: 523-529. 10.1016/S1072-7515(00)00257-X.CrossRefPubMed
6.
go back to reference Lambe M, Hsieh C, Trichopoulos D, Ekbom A, Pavia M, Adami H-O: Transient increase in the risk of breast cancer after giving birth. N Engl J Med. 1994, 331: 5-9. 10.1056/NEJM199407073310102.CrossRefPubMed Lambe M, Hsieh C, Trichopoulos D, Ekbom A, Pavia M, Adami H-O: Transient increase in the risk of breast cancer after giving birth. N Engl J Med. 1994, 331: 5-9. 10.1056/NEJM199407073310102.CrossRefPubMed
7.
go back to reference Tavani A, Gallus S, La Vecchia C, Negri E, Montella M, Dal Maso L, Franceschi S: Risk factors for breast cancer in women under 40 years. Eur J Cancer. 1999, 35: 1361-1367. 10.1016/S0959-8049(99)00139-2.CrossRefPubMed Tavani A, Gallus S, La Vecchia C, Negri E, Montella M, Dal Maso L, Franceschi S: Risk factors for breast cancer in women under 40 years. Eur J Cancer. 1999, 35: 1361-1367. 10.1016/S0959-8049(99)00139-2.CrossRefPubMed
8.
go back to reference Wohlfahrt J, Andersen PK, Mouridsen HT, Melbye M: Risk of late-stage breast cancer after a childbirth. Am J Epidemiol. 2001, 153: 1079-1084. 10.1093/aje/153.11.1079.CrossRefPubMed Wohlfahrt J, Andersen PK, Mouridsen HT, Melbye M: Risk of late-stage breast cancer after a childbirth. Am J Epidemiol. 2001, 153: 1079-1084. 10.1093/aje/153.11.1079.CrossRefPubMed
9.
go back to reference Guinee VF, Olsson H, Moller T, Hess KR, Taylor SH, Fahey T, Gladikov JV, van den Blink JW, Bonichon F, Dische S, et al: Effect of pregnancy on prognosis for young women with breast cancer. Lancet. 1994, 343: 1587-1589. 10.1016/S0140-6736(94)93054-6.CrossRefPubMed Guinee VF, Olsson H, Moller T, Hess KR, Taylor SH, Fahey T, Gladikov JV, van den Blink JW, Bonichon F, Dische S, et al: Effect of pregnancy on prognosis for young women with breast cancer. Lancet. 1994, 343: 1587-1589. 10.1016/S0140-6736(94)93054-6.CrossRefPubMed
10.
go back to reference Phillips KA, Milne RL, Friedlander ML, Jenkins MA, McCredie MR, Giles GG, Hopper JL: Prognosis of premenopausal breast cancer and childbirth prior to diagnosis. J Clin Oncol. 2004, 22: 699-705. 10.1200/JCO.2004.07.062.CrossRefPubMed Phillips KA, Milne RL, Friedlander ML, Jenkins MA, McCredie MR, Giles GG, Hopper JL: Prognosis of premenopausal breast cancer and childbirth prior to diagnosis. J Clin Oncol. 2004, 22: 699-705. 10.1200/JCO.2004.07.062.CrossRefPubMed
11.
go back to reference American Cancer Society, California Division, and Public Health Institute, California Cancer Registry: California Cancer Facts and Figures, 1999. 1999, Oakland, CA: American Cancer Society, California Division American Cancer Society, California Division, and Public Health Institute, California Cancer Registry: California Cancer Facts and Figures, 1999. 1999, Oakland, CA: American Cancer Society, California Division
12.
go back to reference SEER: Surveillance, Epidemiology, and End Results (SEER) Program Public-Use Data (1973–1999). 2002, Bethesda, MD: National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, based on the November 2001 submission SEER: Surveillance, Epidemiology, and End Results (SEER) Program Public-Use Data (1973–1999). 2002, Bethesda, MD: National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, based on the November 2001 submission
13.
go back to reference SEER: Summary Staging Guide for the Cancer Surveillance, Epidemiology and End Results Reporting (SEER) Program. 1977, Bethesda, MD: US Department of Health and Human Services, Public Health Services, National Institutes of Health, reprinted July 1986 SEER: Summary Staging Guide for the Cancer Surveillance, Epidemiology and End Results Reporting (SEER) Program. 1977, Bethesda, MD: US Department of Health and Human Services, Public Health Services, National Institutes of Health, reprinted July 1986
14.
go back to reference American Joint Committee on Cancer: Manual for Staging of Cancer. 1997, Philadelphia, PA: Lippincott-Raven Publishers, 5 American Joint Committee on Cancer: Manual for Staging of Cancer. 1997, Philadelphia, PA: Lippincott-Raven Publishers, 5
15.
go back to reference Bernstein L, Ross RK, Henderson BE: Prospects for the primary prevention of breast cancer. Am J Epidemiol. 1992, 135: 142-152.PubMed Bernstein L, Ross RK, Henderson BE: Prospects for the primary prevention of breast cancer. Am J Epidemiol. 1992, 135: 142-152.PubMed
16.
go back to reference Hiraku Y, Yamashita N, Nishiguchi M, Kawanishi S: Catechol estrogens induce oxidative DNA damage and estradiol enhances cell proliferation. Int J Cancer. 2001, 92: 333-337. 10.1002/ijc.1193.CrossRefPubMed Hiraku Y, Yamashita N, Nishiguchi M, Kawanishi S: Catechol estrogens induce oxidative DNA damage and estradiol enhances cell proliferation. Int J Cancer. 2001, 92: 333-337. 10.1002/ijc.1193.CrossRefPubMed
17.
go back to reference Daling JR, Malone KE, Doody DR, Anderson BO, Porter PL: The relation of reproductive factors to mortality from breast cancer. Cancer Epidemiol Biomarkers Prev. 2002, 11: 235-241.PubMed Daling JR, Malone KE, Doody DR, Anderson BO, Porter PL: The relation of reproductive factors to mortality from breast cancer. Cancer Epidemiol Biomarkers Prev. 2002, 11: 235-241.PubMed
18.
go back to reference Schouten LJ, Hupperets PSGJ, Jager JJ, Volovics L, Wils JA, Verbeek ALM, Blijham GH: Prognostic significance of etiological risk factors in early breast cancer. Breast Cancer Res Treat. 1997, 43: 217-223. 10.1023/A:1005790531122.CrossRefPubMed Schouten LJ, Hupperets PSGJ, Jager JJ, Volovics L, Wils JA, Verbeek ALM, Blijham GH: Prognostic significance of etiological risk factors in early breast cancer. Breast Cancer Res Treat. 1997, 43: 217-223. 10.1023/A:1005790531122.CrossRefPubMed
19.
go back to reference Kroman N, Wohlfahrt J, Andersen KW, Mouridsen HT, Westergaard T, Melbye M: Parity, age at first childbirth and the prognosis of primary breast cancer. Br J Cancer. 1998, 78: 1529-1533.CrossRefPubMedPubMedCentral Kroman N, Wohlfahrt J, Andersen KW, Mouridsen HT, Westergaard T, Melbye M: Parity, age at first childbirth and the prognosis of primary breast cancer. Br J Cancer. 1998, 78: 1529-1533.CrossRefPubMedPubMedCentral
20.
go back to reference Chie WC, Hsieh CC, Newcomb PA, Longnecker MP, Mittendorf R, Greenberg ER, Clapp RW, Burke KP, Titus-Ernstoff L, Tentham-Dietz AM, et al: Age at any full-term pregnancy and breast cancer risk. Am J Epidemiol. 2000, 151: 715-722.CrossRefPubMed Chie WC, Hsieh CC, Newcomb PA, Longnecker MP, Mittendorf R, Greenberg ER, Clapp RW, Burke KP, Titus-Ernstoff L, Tentham-Dietz AM, et al: Age at any full-term pregnancy and breast cancer risk. Am J Epidemiol. 2000, 151: 715-722.CrossRefPubMed
21.
go back to reference Huang W, Newman B, Millikan RC, Schell MJ, Hulka BS, Moorman PG: Hormone-related factors and risk of breast cancer in relation to estrogen receptor and progesterone receptor status. Am J Epidemiol. 2000, 151: 703-714.CrossRefPubMed Huang W, Newman B, Millikan RC, Schell MJ, Hulka BS, Moorman PG: Hormone-related factors and risk of breast cancer in relation to estrogen receptor and progesterone receptor status. Am J Epidemiol. 2000, 151: 703-714.CrossRefPubMed
22.
go back to reference Kroman N, Wholfahrt J, West Andersen K, Mouridsen HT, Westergaard T, Melbye M: Time since childbirth and prognosis in primary breast cancer: population based study. BMJ. 1997, 315: 851-855.CrossRefPubMedPubMedCentral Kroman N, Wholfahrt J, West Andersen K, Mouridsen HT, Westergaard T, Melbye M: Time since childbirth and prognosis in primary breast cancer: population based study. BMJ. 1997, 315: 851-855.CrossRefPubMedPubMedCentral
23.
go back to reference Olson SH, Zauber AG, Tang J, Harlap S: Relation of time since last birth and parity to survival of young women with breast cancer. Epidemiology. 1998, 9: 669-671. 10.1097/00001648-199811000-00015.CrossRefPubMed Olson SH, Zauber AG, Tang J, Harlap S: Relation of time since last birth and parity to survival of young women with breast cancer. Epidemiology. 1998, 9: 669-671. 10.1097/00001648-199811000-00015.CrossRefPubMed
Metadata
Title
Effect of reproductive factors on stage, grade and hormone receptor status in early-onset breast cancer
Authors
Joan A Largent
Argyrios Ziogas
Hoda Anton-Culver
Publication date
01-08-2005
Publisher
BioMed Central
Published in
Breast Cancer Research / Issue 4/2005
Electronic ISSN: 1465-542X
DOI
https://doi.org/10.1186/bcr1198

Other articles of this Issue 4/2005

Breast Cancer Research 4/2005 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine